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S134 DialysisConclusion: Atorvastatin with far-infrared radiation therapy via reducing in-
flammatory factors and thrombosis factors to protect AVF and deserve to be
widely used in clinic.http://dx.doi.org/10.1016/j.hkjn.2015.09.230
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Effect of Peritoneal Dialysis Combined with Hemodialysis on End-stage
Renal Disease
Jing Wu, Yan Zha, Pinghong He
Guizhou Province People’s Hospital, Guiyang, China
Objective: To explore the curative effect of hemodialysis combined with
peritoneal dialysis treating the end-stage renal disease.
Methods: Selected 120 patients who were diagnosed end-stage renal disease
in our department from July 2012 to December 2013. According to the types
of dialysis, they were randomly and equally divided into combination group,
hemodialysis group and peritoneal dialysis group. Follow up for 3 years,
observed renal function, biochemical index, lipid metabolism, renal
morphology and blood flow signal changes, as well as the incidence of com-
plications and survival of three groups befor and after treatment.
Results: After different treatments, renal functions of three groups of patients
were significantly improved. The urea nitrogen (BUN) and serum creatinine
(Scr) of the combination group had no significant difference from hemodialysis
group (P> 0.05), but they were significantly lower than that of peritoneal dial-
ysis group (P < 0.05). The levels of hemoglobin and albumin of the combined
groupwere significantly higher than peritoneal dialysis and hemodialysis group,
and the differences were statistically significant (P< 0.05). Compared with he-
modialysis group, the rising amplitudes of hemoglobin and red blood cells of
peritoneal dialysis were higher (P < 0.05) but the level of albumin (ALB) was
lower (P < 0.05). Compared with peritoneal dialysis group, the combination
group had lower levels of triglyceride (TG), low density lipoprotein (LDL-C),
very low density lipoprotein (VLDL) and a higher level of high-density lipopro-
tein increased (HDL-C) (P < 0.05), but a less significantly different level of
the total cholesterol (TC) (P > 0.05).
Conclusion: Combined dialysis treatment for end-stage renal disease has
better effect, less complications and increased survival rate, and is worth
of clinical promotion.http://dx.doi.org/10.1016/j.hkjn.2015.09.231
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Analysis of Clinical Features of Peritoneal Dialysis-related Peritonitis
Shuang Chen, Yan Zha
Guizhou Province People’s Hospital, Guiyang, China
Objective: To understand the status of clinical features and pathogenic bac-
teria by analyzed the related factor, in order to improve the patients’ qual-
ity of life.
Methods: Selected the patients from January 2012 to December 2014, and
recorded each patient’s gender, age, primary disease, intestinal disorders
(diarrhea or constipation), peritoneal fluid culture, serum albumin, hemo-
globin, serum creatinine, serum calcium, serum phosphorus, parathyroid
hormone, peritoneal dialysis age. Summed up the pathogenic bacteria,
clarify the dangerous factors of PD related peritonitis.
Results: (1) There were 46 cases including 58 times of PD related peritonitis
in total of 126 cases, and 47 cases culture positive in the 58 times of perito-
neal fluid culture, the positive rate was 81.03%, including 29 cases with
Gram-positive cocci (61.70%), Gram-negative bacilli in 12 cases (25.53%), 6
cases of fungus (12.76%). (2) There was no difference between the two group
of patients’ age, gender, dialysis age and primary disease. (3) Peritonitis pa-
tients’ red blood cell, hemoglobin, serum albumin, serum calcium levels
were lower than the control group (P < 0.05). (4) Peritonitis group diar-
rhea/constipation increased significantly compared with the control group
(P < 0.01). (5) Peritonitis group of 58 patients with a total of three deaths,
6 cases changed to hemodialysis, the rest of the patients were cured. The 6
cases of fungal peritonitis, 4 cases had extubation and changed hemodialy-
sis, 2 cases died.
Conclusion: (1) Gram-positive bacteria are the most common pathogens in
PD-related peritonitis. (2) Poor nutrition, anemia, electrolyte disorder,bowel dysfunction are the risk factor of PD-related peritonitis. (3) Fungal
peritonitis had a higher rate of mortality and dropout rates.http://dx.doi.org/10.1016/j.hkjn.2015.09.2320361
Regular Urokinase Intervention in Catheter Maintenance in Patients
with Maintenance Haemodialysis
Ying Hu, Yan Zha, Shan He
Guizhou Province People’s Hospital, Guiyang, China
Objective: Explore the efficacy of Long-term catheter maintenance in ure-
mia patients with regular thrombolysis therapy by urokinase.
Methods: Forty uremia patients were recruited from our hospital between
October 2008 and December 2014. They were all received blood purification
average from 3 to 6 years. All of them were cuff tube. 21 patients were
male, average age, 68.40. They were divided into two groups randomly:
group A (19 cases), they were treated with thrombolysis therapy by uroki-
nase after dialysis. These patients received thrombolysis therapy by uroki-
nase regularly (once every 2 weeks), sealed with heparin when blood
purification were ended. And control group (21 cases) only treated with hep-
arin sealing. Then compare the index changes, such as Bun, Scr, KT/v, PT,
APTT.
Results: Compared blood flow, venous pressure, Bun, Scr, PT and APTT of the
two group patients before treatment. There were no statistically significant
differences (all P > 0.05). The levels of venous pressure of urokinase inter-
vention group on a regular basis was 68 30.5 mmHg, BUN (7.2 3.7 mmol/
l), Scr (200.5 90.4 umol/l), there were statistically significant difference
(all P < 0.05). CRP obviously reduced after the intervention compared
with control group; the blood flow and KT/v obviously increased, there
were statistically significant differences (all P < 0.05). There were no statis-
tically significant differences (all P > 0.05) of PT and APTT. There were 2
cases in the group thrombolysis therapy by urokinase, accounting for 11%.
Ten people in the control group, accounting for 47%. There were no statisti-
cally significant differences (P > 0.05) of bleeding.
Conclusion: Thrombolysis therapy by urokinase regularly can improve the
quality of dialysis patients, reduce the incidence of catheter thrombosis
and extending the service life of the catheter.http://dx.doi.org/10.1016/j.hkjn.2015.09.2330362
Effects of Serum of Hemodialysis Patients on TF and PAI-1 Secretion by
Human Vascular Endothelial Cells During Treatment with Atorvastatin
and Anticoagulant
Wen Zeng, Yan Zha, Ying Hu
Guizhou Province People’s Hospital, Guiyang, China
Objective: To elucidate the effects of serum of patients with hemodialysis
on tissue factor (TF) and plasminogen activator inhibitor-1 (PAl-1) secretion
of human vascular endothelial cells (HUVEC) during treat of atorvastatin and
anticoagulant.
Methods: Twenty patients who snuffbox arteriovenous fistula (SAV) or central
venous catheterization in hemodialysis patients involved were divided into
two groups randomly, 10 patients treated with atorvastatin and anticoagulant
and the others with anticoagulant for 3 months. The blood was collected from
patients at 0 months, 1 month, 2 months, and 3 months during treatment.
Serum TNF-a, IL-1bwere measured by ELlSA. TF and PAl-1 secretion of HUVEC
stimulated with serum of patients with hemodialysis undergoing drug treat-
ment were detected. TF and PAl-1 expression level were assayed by RT- PCR.
Results: TF and PAl-1 secretion were significantly increased in HUVEC stim-
ulated with serum of patients with haemodialysis, but the levels were
decreased after treatment with atorvastatin and anticoagulant. The secre-
tion of TNF-a and IL-1b that atorvastatin and anticoagulant group were lower
than atorvastatin group.
Conclusion: Serum of patients with hemodialysis promote the secretion of
TF and PAI-1 in HUVEC. The dysfunction of HUVEC induced by serum of pa-
tients with hemodialysis may be related to mediators of inflammation. Treat
Dialysis S135with atorvastatin and anticoagulant can relieve the inflammatory reaction
which injure HEVEC and improve endothelial cell functions.http://dx.doi.org/10.1016/j.hkjn.2015.09.2340364
Correlation Analysis of Anxiety and Depression in Relation to Disease
Condition in Patients Undergoing Maintenance Peritoneum Dialysis
B. Y. Song, W. Zuo, J. N. Wang
Shenyang North Hospital Branch, Shenyang, China
Objective: Exploring the development of the emotional disorders in patients
undergoing maintenance peritoneum dialysis, and their relationship with the
correlation factors for peritoneum dialysis.
Methods: 212 maintenance peritoneum dialysis patients, in the Nephrology
Department of Shenyang North Hospital, from 2008 to 2015, were selected
to receive assessment of their emotional state and calculate their morbidity
rate using SelfdRating Anxiety Scale (SAS), Self-Rating Depression Scale
(SDS), and Symptom Check List-90; the incidences of diabetes mellitus and
cardio-cerebrovascular events were summarized; the hemodialysis suffi-
ciency, level of inflammation, and nutritional state were determined; and
the educational level and their relatives were collected.
Results: Among the 212 patients, 143 developed the anxiety symptoms, 101
developed the depression symptoms contributing to an incidence of 67.5%
and 47.6% separately. 138 patients with diabetes mellitus history. 45 pa-
tients of cardio-cerebrovascular diseases history, with the SAS, SDS and
Symptom Check score higher than that without history of cardio-cerebrovas-
cular diseases (P < 0.05). There was poor correlation between these scores
and total Kt/V and total creatinine clearance, suggesting no statistical sig-
nificances. Hypersensitive CRP level was not significantly elevated in pa-
tients providing SAS, SDS and Symptom Check score, and no significant
difference in hypersensitive CRP level between patients with higher and
lower scores (P < 0.05). Higher educational attainment was not associated
with higher SAS, SDS or Symptom Check score, and there was no significant
association between the educational attainment and the SAS, SDS or Symp-
tom Check score in the patients with higher scores.
Conclusion: The incidences of anxiety and depression symptoms are rela-
tively high in patients undergoing peritoneum dialysis; the anxiety and
depression symptoms are correlated with the development of diabetes mel-
litus, cardio diseases and malnutrition, yet not correlated with the hemodi-
alysis sufficiency, inflammation level, or the educational attainment of the
patients or their relatives.http://dx.doi.org/10.1016/j.hkjn.2015.09.2350377
Impact of Arteriovenous Fistula Blood Flow on Serum IL-6,
Cardiovascular Events and Death in Chinese Patients Receiving
Hemodialysis: A 5-year Follow-up
Zhizhi Hu, Pengge Wang, Rui Zeng, Gang Xu
Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, China
Objective: Flows (Qa) of arteriovenous fistula (AVF) impact dialysis ade-
quacy and complications in hemodialysis (HD) patients. However, data
from studies of different access flow rate on outcomes related to long-
term dialysis patients, especially in Chinese patients, are limited. To address
this, the correlation between the AVF flows with inflammation and cardio-
vascular events were investigated to explore the optimal AVF flow rate for
maintenance hemodialysis patients.
Methods: Sixty-four hemodialysis patients bearing an arteriovenous fistula
(AVF) on average 2 years were recruited into the study. Qa and cardiac
output (CO) were measured by means of Transonic Hemodialysis Monitor
HD02. Predialysis interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-10
(IL-10) and tumor necrosis factor (TNF-a) were measured by Cytometric
Bead Array (BDTM). Cardiovascular morbidity and mortality were monitored
prospectively over a 5-year period.
Results: 23 patients (35.9%) developed at least one episode of cardiovascu-
lar event during the time of AVF creation to the date of enrollment. Qa, IL-6
and hsCRP were significantly higher in patients with CVD than that without
CVD. Patients with higher IL-6 had the higher level Qa and CVD morbidity
compared to low IL-6 group. Multi-factors binary logistic regression analysis
found IL-6 was an independent and stronger risk factor for CVD. Spearman
rank correlation analysis and liner regression analysis showed that Qa was
positively correlated with IL-6. During the five years follow-up, patients
with median AVF Qa (821.12 ml/min  Qa  1027.13 ml/min) showed the
lowest morbidity and mortality of CVD according to the Qa tertiles, whereas
higher Qa (> 1027.13 ml/min) was associated with a higher risk of CVD, and
lower Qa (600 ml/min  Qa < 821.12 ml/min) had a higher risk of non-CVD
death.
Conclusion: In patients undergoing dialysis, IL-6 is an independent and
strong risk factor of CVD, and it is positively correlated with vascular access
flow (Qa). The AVF Qa at median level benefits the long-term HD patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.236
